
Basecamp Research Lands $140M to Scale AI-Designed Therapeutics
Basecamp Research has secured $140 million in an oversubscribed Series C funding round to propel its generative AI models toward clinical development. The London and Boston-based firm aims to move beyond traditional drug discovery by using its proprietary EDEN platform to design complex therapeutics that reprogram the body to repair itself.
























